Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma

Wim van Boxtel; Eline Boon; Willem L.J. Weijs; Frank J.A. van den Hoogen; Uta E. Flucke; Carla M L Van Herpen

doi:10.1016/j.oraloncology.2017.06.023

Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma

Wim van Boxtel, Eline Boon, Willem L.J. Weijs, Frank J.A. van den Hoogen, Uta E. Flucke, Carla M L Van Herpen

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	198-200
Number of pages	3
Journal	Oral Oncology
Volume	72
DOIs	https://doi.org/10.1016/j.oraloncology.2017.06.023
Publication status	Published - Sept 2017
Externally published	Yes

Keywords

Ado-trastuzumab emtansine
Docetaxel
Head and Neck Neoplasms
Neoplasm metastasis
Pertuzumab
Receptor, ErbB-2
Salivary duct carcinoma
Salivary gland neoplasms
Trastuzumab

Access to Document

10.1016/j.oraloncology.2017.06.023

Cite this

@article{16a9e6c985c14a05a829151ae69c4536,

title = "Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma",

keywords = "Ado-trastuzumab emtansine, Docetaxel, Head and Neck Neoplasms, Neoplasm metastasis, Pertuzumab, Receptor, ErbB-2, Salivary duct carcinoma, Salivary gland neoplasms, Trastuzumab",

author = "{van Boxtel}, Wim and Eline Boon and Weijs, {Willem L.J.} and {van den Hoogen}, {Frank J.A.} and Flucke, {Uta E.} and {Van Herpen}, {Carla M L}",

year = "2017",

month = sep,

doi = "10.1016/j.oraloncology.2017.06.023",

language = "English",

volume = "72",

pages = "198--200",

journal = "Oral Oncology",

issn = "1368-8375",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma

AU - van Boxtel, Wim

AU - Boon, Eline

AU - Weijs, Willem L.J.

AU - van den Hoogen, Frank J.A.

AU - Flucke, Uta E.

AU - Van Herpen, Carla M L

PY - 2017/9

Y1 - 2017/9

KW - Ado-trastuzumab emtansine

KW - Docetaxel

KW - Head and Neck Neoplasms

KW - Neoplasm metastasis

KW - Pertuzumab

KW - Receptor, ErbB-2

KW - Salivary duct carcinoma

KW - Salivary gland neoplasms

KW - Trastuzumab

UR - http://www.scopus.com/inward/record.url?scp=85021691944&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2017.06.023

DO - 10.1016/j.oraloncology.2017.06.023

M3 - Comment/Letter to the editor

AN - SCOPUS:85021691944

SN - 1368-8375

VL - 72

SP - 198

EP - 200

JO - Oral Oncology

JF - Oral Oncology

ER -

Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma

Keywords

Access to Document

Other files and links

Cite this